A home-based walking program using rhythmic auditory stimulation improves gait performance in patients with multiple sclerosis: a pilot study

Neurorehabilitation and Neural Repair
Dwyer ConklynFrancois Bethoux

Abstract

Few interventions have been successful in improving gait dysfunction in patients with multiple sclerosis (MS). Rhythmic auditory stimulation (RAS) has demonstrated positive results on gait performance in other neurologically impaired populations. To measure the effects of RAS on quantitative walking parameters in ambulatory patients with MS. Ten MS patients with gait disturbance were randomly assigned to receive RAS versus no intervention for 2 weeks. All participants received RAS for another 2 weeks. Between weekly clinic visits, they were provided with MP3 players containing songs whose tempo was 10% above the participant's spontaneous cadence and were instructed to walk to the music 20 minutes daily. Quantitative gait parameters were measured using the GAITRite system. A statistically significant decrease between groups was found for change in double-support time (left, P = .0176; right, P = .0247), whereas trends with medium to high effect sizes were found for other gait parameters, including walking speed. A pooled within-group analysis showed significant improvement of cadence, stride length, step length, velocity, and normalized velocity after 1 week of treatment. Satisfaction level with RAS was high. These results in a ...Continue Reading

References

Jul 1, 1976·Electroencephalography and Clinical Neurophysiology·S Rossignol, G M Jones
Apr 1, 1996·Annals of Neurology·J H PetajanR W Hicks
Feb 1, 1996·Electroencephalography and Clinical Neurophysiology·R A MillerR R Rice
Mar 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·M H ThautJ M Brault
Jan 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·G C McIntoshM H Thaut
Dec 31, 1997·Journal of the Neurological Sciences·M H ThautR R Rice
Feb 13, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·C M WilesA Morgan
Mar 21, 2003·Neurorehabilitation and Neural Repair·M P BarnesK M McMullen
Dec 19, 2003·Annals of the New York Academy of Sciences·Marco MolinariMichael Thaut
Dec 14, 2005·Archives of Physical Medicine and Rehabilitation·Deborah E ThorpeCharity G Moore
Aug 16, 2006·Archives of Neurology·Douglas E GladstonePatricia K Coyle
Nov 8, 2006·Multiple Sclerosis : Clinical and Laboratory Research·C L MartinM P Galea
Feb 24, 2007·Journal of the Neurological Sciences·Yoram Baram, Ariel Miller
Apr 6, 2007·Neurorehabilitation and Neural Repair·D KosS Ilsbroukx
Oct 24, 2007·The European Journal of Neuroscience·Jeffrey M HausdorffNir Giladi
Jan 18, 2008·Clinical Techniques in Small Animal Practice·Renee Shumway
May 29, 2008·Multiple Sclerosis : Clinical and Laboratory Research·C HeesenS M Gold
Oct 25, 2008·Neurorehabilitation and Neural Repair·Erin M Snook, Robert W Motl
Oct 31, 2008·Neurorehabilitation and Neural Repair·Albert C Lo, Elizabeth W Triche
Oct 31, 2008·Neurorehabilitation and Neural Repair·Mark G BowdenSteven A Kautz
Mar 3, 2009·Lancet·Andrew D GoodmanUNKNOWN Fampridine MS-F203 Investigators
May 28, 2009·Neurorehabilitation and Neural Repair·Gail L WidenerCynthia Gibson-Horn
May 1, 2007·Journal of Oncology Practice·Douglas W Blayney

❮ Previous
Next ❯

Citations

Jul 25, 2012·Nature Reviews. Neurology·Robert W Motl, Lara A Pilutti
Apr 16, 2014·Multiple Sclerosis International·Brian M SandroffRobert W Motl
Apr 3, 2012·Sports Medicine·Catrine Tudor-Locke, David A Rowe
Apr 20, 2013·Physical Medicine and Rehabilitation Clinics of North America·Lara A Pilutti, Audrey L Hicks
Sep 4, 2015·Journal of Music Therapy·Natalie de BruinLesley A Brown
Jul 26, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Adelaida María Castro-SánchezCarmen Moreno-Lorenzo
Aug 22, 2013·Journal of the Neurological Sciences·Lara A PiluttiRobert W Motl
May 3, 2011·Gait & Posture·Jacob J SosnoffRobert W Motl
Mar 17, 2015·Gait & Posture·Jacob J SosnoffRobert W Motl
Oct 14, 2014·Frontiers in Human Neuroscience·Rachel L Wright, Mark T Elliott
Mar 15, 2012·Journal of Geriatric Physical Therapy·Heather J BradenScott Hasson
Apr 9, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Barbara SeebacherThomas Berger
Oct 13, 2011·Neurorehabilitation and Neural Repair·Bruce H Dobkin, Andrew Dorsch
Jun 12, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Morten RiemenschneiderUlrik Dalgas
Jan 20, 2017·The Cochrane Database of Systematic Reviews·Wendy L MageeJoke Bradt
Jul 31, 2020·Expert Review of Neurotherapeutics·Bernardita SolerPeter Feys
Jul 14, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Claudia VinciguerraAntonio Federico
Dec 12, 2019·JMIR Rehabilitation and Assistive Technologies·Kedar Kv MateNancy E Mayo
Feb 28, 2019·Frontiers in Psychology·Nina SchaffertMichael H Thaut
Oct 24, 2020·Journal of Music Therapy·Sarah ThompsonRobert G Kowalski
Feb 11, 2021·Healthcare·Katarzyna Nowakowska-LipiecAndrzej W Mitas
Jan 3, 2021·Multiple Sclerosis and Related Disorders·Maria Grazia MaggioRocco Salvatore Calabrò
Feb 4, 2019·Neurophysiologie clinique = Clinical neurophysiology·Pierre Decavel, Yoshimasa Sagawa
Jun 25, 2021·Expert Review of Medical Devices·Marco TramontanoGiovanni Morone
Jun 13, 2021·Human Movement Science·Alexandra Hildebrandt, Rouwen Cañal-Bruland
Jul 29, 2021·Arquivos de neuro-psiquiatria·Josiane Lopes, Ivo Ilvan Keppers
Aug 4, 2021·Multiple Sclerosis and Related Disorders·Majid Mardaniyan GhahfarrokhiRobert W Motl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.